Entry, intracellular survival, and multinucleatedgiant- cell-forming activity of Burkholderia pseudomallei in human primary phagocytic and nonphagocytic cells

Infection and Immunity

Volumn 85, Issue 10, 2017, Pages

  Whiteley, Liam ^a   Meffert, Teresa ^a   Haug, Maria ^a   Weidenmaier, Christopher ^a   Hopf, Verena ^b   Bitschar, Katharina ^a   Schittek, Birgit ^a   Kohler, Christian ^b   Steinmetz, Ivo ^b   West, T Eoin ^c   Schwarz, Sandra ^a,d  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b UNIVERSITY MEDICINE GREIFSWALD   (Germany)

^c UNIVERSITY OF WASHINGTON   (United States)

^d MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

Burkholderia pseudomallei; Primary cells; Type VI secretion system

Indexed keywords

ANIMAL CELL; ARTICLE; BACTERIAL CELL; BACTERIAL LOAD; BACTERIAL STRAIN; BACTERIAL SURVIVAL; BACTERICIDAL ACTIVITY; BACTERIUM MUTANT; BRONCHUS EPITHELIUM; BURKHOLDERIA PSEUDOMALLEI; BURKHOLDERIA THAILANDENSIS; COLONY FORMING UNIT; ENDOTHELIUM CELL; EPITHELIAL CELL LINE; FIBROBLAST; GIANT CELL; GIEMSA STAIN; HOST CELL; HOST PATHOGEN INTERACTION; HUMAN; HUMAN CELL; HUMAN TISSUE; HUVEC CELL LINE; KERATINOCYTE; MACROPHAGE; MELIOIDOSIS; MESENCHYMAL STEM CELL; MONOCYTE; MOUSE; NEUTROPHIL; NONHUMAN; PATHOGENESIS; PHAGOCYTE; PRIMARY CELL; PRIORITY JOURNAL; RAW 264.7 CELL LINE; TYPE VI SECRETION SYSTEM; ANIMAL; BRONCHUS; CELL CULTURE; CELL LINE; CYTOLOGY; CYTOSOL; EPITHELIUM CELL; GROWTH, DEVELOPMENT AND AGING; METABOLISM; MICROBIOLOGY; PATHOGENICITY; PHYSIOLOGY; VIRULENCE;

TYPE VI SECRETION SYSTEM;

ANIMALS; BRONCHI; BURKHOLDERIA PSEUDOMALLEI; CELL LINE; CELLS, CULTURED; CYTOSOL; ENDOTHELIAL CELLS; EPITHELIAL CELLS; FIBROBLASTS; GIANT CELLS; HOST-PATHOGEN INTERACTIONS; HUMANS; KERATINOCYTES; MACROPHAGES; MICE; NEUTROPHILS; PHAGOCYTES; TYPE VI SECRETION SYSTEMS; VIRULENCE;

EID: 85029745403     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00468-17     Document Type: Article

References (55)

1. Thomas AD, Forbes-Faulkner J, Parker M. 1979. Isolation of Pseudomonas pseudomallei from clay layers at defined depths. Am J Epidemiol 110: 515-521. https://doi.org/10.1093/oxfordjournals.aje.a112832
2. Wiersinga WJ, van der Poll T, White NJ, Day NP, Peacock SJ. 2006. Melioidosis: insights into the pathogenicity of Burkholderia pseudomallei. Nat Rev Microbiol 4:272-282. https://doi.org/10.1038/nrmicro1385
3. Limmathurotsakul D, Wongratanacheewin S, Teerawattanasook N, Wongsuvan G, Chaisuksant S, Chetchotisakd P, Chaowagul W, Day NP, Peacock SJ. 2010. Increasing incidence of human melioidosis in Northeast Thailand. Am J Trop Med Hyg 82:1113-1117. https://doi.org/10.4269/ajtmh.2010.10-0038
4. Limmathurotsakul D, Golding N, Dance DA, Messina JP, Pigott DM, Moyes CL, Rolim DB, Bertherat E, Day NP, Peacock SJ, Hay SI. 2016. Predicted global distribution of and burden of melioidosis. Nat Microbiol 1(1):15008
5. Currie BJ, Ward L, Cheng AC. 2010. The epidemiology and clinical spectrum of melioidosis: 540 cases from the 20 year Darwin prospective study. PLoS Negl Trop Dis 4:e900. https://doi.org/10.1371/journal.pntd.0000900
6. Easton A, Haque A, Chu K, Lukaszewski R, Bancroft GJ. 2007. A critical role for neutrophils in resistance to experimental infection with Burkholderia pseudomallei. J Infect Dis 195:99-107. https://doi.org/10.1086/ 509810
7. Wiersinga WJ, Veer C, Wieland CW, Gibot S, Hooibrink B, Day NP, Peacock SJ, van der Poll T. 2007. Expression profile and function of triggering receptor expressed on myeloid cells-1 during melioidosis. J Infect Dis 196:1707-1716. https://doi.org/10.1086/522141
8. Jones AL, Beveridge TJ, Woods DE. 1996. Intracellular survival of Burkholderia pseudomallei. Infect Immun 64:782-790
9. Harley VS, Dance DA, Drasar BS, Tovey G. 1998. Effects of Burkholderia pseudomallei and other Burkholderia species on eukaryotic cells in tissue culture. Microbios 96:71-93
10. Stevens MP, Friebel A, Taylor LA, Wood MW, Brown PJ, Hardt WD, Galyov EE. 2003. A Burkholderia pseudomallei type III secreted protein, BopE, facilitates bacterial invasion of epithelial cells and exhibits guanine nucleotide exchange factor activity. J Bacteriol 185:4992-4996. https:// doi.org/10.1128/JB.185.16.4992-4996.2003
11. Utaisincharoen P, Arjcharoen S, Lengwehasatit I, Limposuwan K, Sirisinha S. 2005. Burkholderia pseudomallei invasion and activation of epithelial cells requires activation of p38 mitogen-activated protein kinase. Microb Pathog 38:107-112. https://doi.org/10.1016/j.micpath.2004.12.006
12. Vanaporn M, Wand M, Michell SL, Sarkar-Tyson M, Ireland P, Goldman S, Kewcharoenwong C, Rinchai D, Lertmemongkolchai G, Titball RW. 2011. Superoxide dismutase C is required for intracellular survival and virulence of Burkholderia pseudomallei. Microbiology 157:2392-2400. https://doi.org/10.1099/mic.0.050823-0
13. Horton RE, Morrison NA, Beacham IR, Peak IR. 2012. Interaction of Burkholderia pseudomallei and Burkholderia thailandensis with human monocyte-derived dendritic cells. J Med Microbiol 61:607-614. https:// doi.org/10.1099/jmm.0.038588-0
14. Williams NL, Morris JL, Rush CM, Ketheesan N. 2014. Migration of dendritic cells facilitates systemic dissemination of Burkholderia pseudomallei. Infect Immun 82:4233-4240. https://doi.org/10.1128/IAI.01880-14
15. Stevens MP, Stevens JM, Jeng RL, Taylor LA, Wood MW, Hawes P, Monaghan P, Welch MD, Galyov EE. 2005. Identification of a bacterial factor required for actin-based motility of Burkholderia pseudomallei. Mol Microbiol 56:40-53. https://doi.org/10.1111/j.1365-2958.2004.04528.x
16. Benanti EL, Nguyen CM, Welch MD. 2015. Virulent Burkholderia species mimic host actin polymerases to drive actin-based motility. Cell 161: 348-360. https://doi.org/10.1016/j.cell.2015.02.044
17. French CT, Toesca IJ, Wu TH, Teslaa T, Beaty SM, Wong W, Liu M, Schroder I, Chiou PY, Teitell MA, Miller JF. 2011. Dissection of the Burkholderia intracellular life cycle using a photothermal nanoblade. Proc Natl Acad Sci U S A 108:12095-12100. https://doi.org/10.1073/pnas.1107183108
18. Kespichayawattana W, Rattanachetkul S, Wanun T, Utaisincharoen P, Sirisinha S. 2000. Burkholderia pseudomallei induces cell fusion and actin-associated membrane protrusion: a possible mechanism for cellto-cell spreading. Infect Immun 68:5377-5384. https://doi.org/10.1128/ IAI.68.9.5377-5384.2000
19. Conejero L, Patel N, de Reynal M, Oberdorf S, Prior J, Felgner PL, Titball RW, Salguero FJ, Bancroft GJ. 2011. Low-dose exposure of C57BL/6 mice to Burkholderia pseudomallei mimics chronic human melioidosis. Am J Pathol 179:270-280. https://doi.org/10.1016/j.ajpath.2011.03.031
20. Wong KT, Puthucheary SD, Vadivelu J. 1995. The histopathology of human melioidosis. Histopathology 26:51-55. https://doi.org/10.1111/j.1365-2559.1995.tb00620.x
21. Fisher NA, Ribot WJ, Applefeld W, DeShazer D. 2012. The Madagascar hissing cockroach as a novel surrogate host for Burkholderia pseudomallei, B. mallei, and B. thailandensis. BMC Microbiol 12:117. https://doi.org/ 10.1186/1471-2180-12-117
22. Pukatzki S, Ma AT, Revel AT, Sturtevant D, Mekalanos JJ. 2007. Type VI secretion system translocates a phage tail spike-like protein into target cells where it cross-links actin. Proc Natl Acad Sci U S A 104: 15508-15513. https://doi.org/10.1073/pnas.0706532104
23. Basler M, Pilhofer M, Henderson GP, Jensen GJ, Mekalanos JJ. 2012. Type VI secretion requires a dynamic contractile phage tail-like structure. Nature 483:182-186. https://doi.org/10.1038/nature10846
24. Cascales E, Cambillau C. 2012. Structural biology of type VI secretion systems. Philos Trans R Soc Lond B Biol Sci 367:1102-1111. https://doi.org/10.1098/rstb.2011.0209
25. Hood RD, Singh P, Hsu F, Guvener T, Carl MA, Trinidad RR, Silverman JM, Ohlson BB, Hicks KG, Plemel RL, Li M, Schwarz S, Wang WY, Merz AJ, Goodlett DR, Mougous JD. 2010. A type VI secretion system of Pseudomonas aeruginosa targets a toxin to bacteria. Cell Host Microbe 7:25-37. https://doi.org/10.1016/j.chom.2009.12.007
26. Schell MA, Ulrich RL, Ribot WJ, Brueggemann EE, Hines HB, Chen D, Lipscomb L, Kim HS, Mrazek J, Nierman WC, Deshazer D. 2007. Type VI secretion is a major virulence determinant in Burkholderia mallei. Mol Microbiol 64:1466-1485. https://doi.org/10.1111/j.1365-2958.2007.05734.x
27. Burtnick MN, Brett PJ, Harding SV, Ngugi SA, Ribot WJ, Chantratita N, Scorpio A, Milne TS, Dean RE, Fritz DL, Peacock SJ, Prior JL, Atkins TP, Deshazer D. 2011. The cluster 1 type VI secretion system is a major virulence determinant in Burkholderia pseudomallei. Infect Immun 79: 1512-1525. https://doi.org/10.1128/IAI.01218-10
28. Schwarz S, Singh P, Robertson JD, LeRoux M, Skerrett SJ, Goodlett DR, West TE, Mougous JD. 2014. VgrG-5 is a Burkholderia type VI secretion system-exported protein required for multinucleated giant cell formation and virulence. Infect Immun 82:1445-1452. https://doi.org/10.1128/ IAI.01368-13
29. Toesca IJ, French CT, Miller JF. 2014. The type VI secretion system spike protein VgrG5 mediates membrane fusion during intercellular spread by pseudomallei group Burkholderia species. Infect Immun 82:1436-1444. https://doi.org/10.1128/IAI.01367-13
30. Pilatz S, Breitbach K, Hein N, Fehlhaber B, Schulze J, Brenneke B, Eberl L, Steinmetz I. 2006. Identification of Burkholderia pseudomallei genes required for the intracellular life cycle and in vivo virulence. Infect Immun 74:3576-3586. https://doi.org/10.1128/IAI.01262-05
31. Schwarz S, West TE, Boyer F, Chiang WC, Carl MA, Hood RD, Rohmer L, Tolker-Nielsen T, Skerrett SJ, Mougous JD. 2010. Burkholderia type VI secretion systems have distinct roles in eukaryotic and bacterial cell interactions. PLoS Pathog 6:e1001068. https://doi.org/10.1371/journal.ppat.1001068
32. Wong J, Chen Y, Gan YH. 2015. Host cytosolic glutathione sensing by a membrane histidine kinase activates the type VI secretion system in an intracellular bacterium. Cell Host Microbe 18:38-48. https://doi.org/10.1016/j.chom.2015.06.002
33. Ye Z, Lee CM, Sun GW, Gan YH. 2008. Burkholderia pseudomallei infection of T cells leads to T-cell costimulation partially provided by flagellin. Infect Immun 76:2541-2550. https://doi.org/10.1128/IAI.01310-07
34. Sim SH, Liu Y, Wang D, Novem V, Sivalingam SP, Thong TW, Ooi EE, Tan G. 2009. Innate immune responses of pulmonary epithelial cells to Burkholderia pseudomallei infection. PLoS One 4:e7308. https://doi.org/ 10.1371/journal.pone.0007308
35. Bast A, Schmidt IH, Brauner P, Brix B, Breitbach K, Steinmetz I. 2011. Defense mechanisms of hepatocytes against Burkholderia pseudomallei. Front Microbiol 2:277. https://doi.org/10.3389/fmicb.2011.00277
36. Lu R, Popov V, Patel J, Eaves-Pyles T. 2012. Burkholderia mallei and Burkholderia pseudomallei stimulate differential inflammatory responses from human alveolar type II cells (ATII) and macrophages. Front Cell Infect Microbiol 2:165. https://doi.org/10.3389/fcimb.2012.00165
37. Boddey JA, Day CJ, Flegg CP, Ulrich RL, Stephens SR, Beacham IR, Morrison NA, Peak IR. 2007. The bacterial gene lfpA influences the potent induction of calcitonin receptor and osteoclast-related genes in Burkholderia pseudomallei-induced TRAP-positive multinucleated giant cells. Cell Microbiol 9:514-531. https://doi.org/10.1111/j.1462-5822.2006.00807.x
38. Pegoraro G, Eaton BP, Ulrich RL, Lane DJ, Ojeda JF, Bavari S, DeShazer D, Panchal RG. 2014. A high-content imaging assay for the quantification of the Burkholderia pseudomallei induced multinucleated giant cell (MNGC) phenotype in murine macrophages. BMC Microbiol 14:98. https://doi.org/10.1186/1471-2180-14-98
39. Suparak S, Muangsombut V, Riyapa D, Stevens JM, Stevens MP, Lertmemongkolchai G, Korbsrisate S. 2011. Burkholderia pseudomalleiinduced cell fusion in U937 macrophages can be inhibited by monoclonal antibodies against host cell surface molecules. Microbes Infect 13: 1006-1011. https://doi.org/10.1016/j.micinf.2011.06.007
40. Welkos SL, Klimko CP, Kern SJ, Bearss JJ, Bozue JA, Bernhards RC, Trevino SR, Waag DM, Amemiya K, Worsham PL, Cote CK. 2015. Characterization of Burkholderia pseudomallei strains using a murine intraperitoneal infection model and in vitro macrophage assays. PLoS One 10:e0124667. https://doi.org/10.1371/journal.pone.0124667
41. Hopf V, Gohler A, Eske-Pogodda K, Bast A, Steinmetz I, Breitbach K. 2014. BPSS1504, a cluster 1 type VI secretion gene, is involved in intracellular survival and virulence of Burkholderia pseudomallei. Infect Immun 82: 2006-2015. https://doi.org/10.1128/IAI.01544-14
42. Breitbach K, Rottner K, Klocke S, Rohde M, Jenzora A, Wehland J, Steinmetz I. 2003. Actin-based motility of Burkholderia pseudomallei involves the Arp 2/3 complex, but not N-WASP and Ena/VASP proteins. Cell Microbiol 5:385-393. https://doi.org/10.1046/j.1462-5822.2003.00277.x
43. Liu PJ, Chen YS, Lin HH, Ni WF, Hsieh TH, Chen HT, Chen YL. 2013. Induction of mouse melioidosis with meningitis by CD11b+ phagocytic cells harboring intracellular B. pseudomallei as a Trojan horse. PLoS Negl Trop Dis 7:e2363. https://doi.org/10.1371/journal.pntd.0002363
44. St John JA, Ekberg JA, Dando SJ, Meedeniya AC, Horton RE, Batzloff M, Owen SJ, Holt S, Peak IR, Ulett GC, Mackay-Sim A, Beacham IR. 2014. Burkholderia pseudomallei penetrates the brain via destruction of the olfactory and trigeminal nerves: implications for the pathogenesis of neurological melioidosis. mBio 5:e00025-14. https://doi.org/10.1128/ mBio.00025-14
45. Stins MF, Badger J, Sik Kim K. 2001. Bacterial invasion and transcytosis in transfected human brain microvascular endothelial cells. Microb Pathog 30:19-28. https://doi.org/10.1006/mpat.2000.0406
46. Sheen TR, Ebrahimi CM, Hiemstra IH, Barlow SB, Peschel A, Doran KS. 2010 Penetration of the blood-brain barrier by Staphylococcus aureus: contribution of membrane-anchored lipoteichoic acid. J Mol Med (Berl) 88:633-639. https://doi.org/10.1007/s00109-010-0630-5
47. Suparak S, Kespichayawattana W, Haque A, Easton A, Damnin S, Lertmemongkolchai G, Bancroft GJ, Korbsrisate S. 2005. Multinucleated giant cell formation and apoptosis in infected host cells is mediated by Burkholderia pseudomallei type III secretion protein BipB. J Bacteriol 187:6556-6560. https://doi.org/10.1128/JB.187.18.6556-6560.2005
48. Amornrit W, Muangsombut V, Wangteeraprasert T, Korbsrisate S. 2012. Elevated intracellular levels of iron in host cells promotes Burkholderia pseudomallei infection. Asian Biomed 6:465-471
49. Chanchamroen S, Kewcharoenwong C, Susaengrat W, Ato M, Lertmemongkolchai G. 2009. Human polymorphonuclear neutrophil responses to Burkholderia pseudomallei in healthy and diabetic subjects. Infect Immun 77:456-463. https://doi.org/10.1128/IAI.00503-08
50. Pruksachartvuthi S, Aswapokee N, Thankerngpol K. 1990. Survival of Pseudomonas pseudomallei in human phagocytes. J Med Microbiol 31: 109-114. https://doi.org/10.1099/00222615-31-2-109
51. Fogh J, Fogh JM, Orfeo T. 1977. One hundred and twenty-seven cultured human tumor cell lines producing tumors in nude mice. J Natl Cancer Inst 59:221-226. https://doi.org/10.1093/jnci/59.1.221
52. Mickey DD, Stone KR, Wunderli H, Mickey GH, Vollmer RT, Paulson DF. 1977 Heterotransplantation of a human prostatic adenocarcinoma cell line in nude mice. Cancer Res 37:4049-4058
53. Schmidt M, Deschner EE, Thaler HT, Clements L, Good RA. 1977. Gastrointestinal cancer studies in the human to nude mouse heterotransplant system. Gastroenterology 72:829-837
54. Lieber M, Mazzetta J, Nelson-Rees W, Kaplan M, Todaro G. 1975. Establishment of a continuous tumor-cell line (panc-1) from a human carcinoma of the exocrine pancreas. Int J Cancer 15:741-747. https://doi.org/ 10.1002/ijc.2910150505
55. Lasfargues EY, Ozzello L. 1958. Cultivation of human breast carcinomas. J Natl Cancer Inst 21:1131-1147